Close Menu

NEW YORK – The US Attorney's Office, Western District of Wisconsin said on Monday that molecular diagnostics firm AutoGenomics has agreed to pay more than $2.5 million to settle allegations that it violated the US False Claims Act and Anti-Kickback Statute.

The Carlsbad, California-based company is alleged to have been involved in a scheme to bill Medicare for molecular genetic tests performed on nursing home patients who were paid in exchange for the referral of the tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.